公司資料
Statera Biopharma 股價、新聞與催化劑
- 股票代碼:
- STAB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月24日
—
市值
股價為何變動
As of Aug 24, 2026, STAB was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Statera Biopharma was an immunotherapy and inflammation-focused biotechnology company that pursued immune modulation in difficult diseases. Its story was rooted in narrow development programs and the challenge of keeping a micro-cap platform alive.
所在地與產業分類
Statera is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
商業模式特徵
The company depended on clinical progress, restructuring, and capital preservation. Investors historically watched whether the platform could generate enough data to justify continued development.
生技產業定位
Statera occupies a historical micro-cap immunology niche within biotech. The stock was always highly sensitive to financing and program-level updates.
未來催化劑
- Statera is a legacy / closeout story, with catalysts limited to any remaining strategic or asset-resolution update. There is no active standalone growth story left.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。